The removal of pharmaceuticals (PhACs) present in urban wastewater by membrane bioreactors (MBRs) followed by reverse osmosis (RO) or nanofiltration (NF) membranes has been frequently addressed in the literature. However, data regarding the removal of their main human metabolites and transformation products (TPs) is still scarce. In this study, the presence of 13 PhACs and 20 of their metabolites and TPs was monitored during 2 consecutive years in the different treatment steps of urban raw wastewater (sewer, primary treatment, MBR and RO/NF). Rejection of the selected contaminants when using low pressure NF membranes (NF-90) or RO membranes (ESPA 2) after the MBR step was also investigated. The analgesic acetaminophen, which was found at the highest concentrations in the sewer and influent samples (18–74 µg L-1) over the two experimental periods, was fully eliminated during MBR treatment. Those PhACs that were only partially removed after the MBR, were almost completely removed (>99%) by the RO membrane working under different process conditions. At a similar average permeate fluxes (18 L m-2 h-1), the NF membrane showed high removal efficiencies (>90%) for all of the PhACs and their metabolites, though lower than those achieved by the RO membrane. When the flux of the NF90 membrane was increased to 30 L m-2 h-1 (while still operating at a feed pressure lower than the RO membrane at 18 L m-2 h-1) the performance of the membrane increased, achieving 98% rejection of PhACs.Peer ReviewedPostprint (author's final draft
The option of building smaller, decentralized plants is more feasible now that HP pumps and energy recovery devices (ERD) are available for use in small-scale seawater desalination plants with efficiencies comparable to those typically associated with larger plants. A demonstration SWRO system producing 125 cubic meters of product water per day was designed and commissioned utilizing the Danfoss iSave 21 energy recovery device. The desalination subsystem utilizes an inter-staged membrane configuration, low flux, and low recovery design to reduce specific energy consumption, fouling potential, and membrane cleaning requirements. Test results show that a specific energy consumption lower than 2 kWh/m3 is easily achievable utilizing standard components, and that the improved second-generation iSave 21 unit has significantly lower lubrication flows than the previous model.
1 January 2013 in Desalination and Water Treatment
Energy remains the major operating expense when producing desalted water by seawater reverse osmosis (SWRO). Recent advances in membrane materials and highly efficient energy recovery devices have drastically reduced the energy required to desalinate seawater over a wide range of system capacities. This study tests the performance of novel, commercially available, high-permeability membranes (including nanocomposite membranes) over an extended period of time. Tests were carried out utilizing a 125 m3/day SWRO system with independently verified continuous power monitoring. The desalination subsystem utilizes a staged membrane configuration and a low flux—low recovery design to minimize the overall energy consumption, reduce potential fouling, and reduce membrane cleaning. The specific power required to desalinate water to produce potable water having total dissolved solids below 400 mg/L was consistently below 2.0 kWh/m3 for feedwater temperatures above 20 °C using commercially available high pressure pumps and energy recovery devices.